Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening.
作者信息
Vollmer Tanja, Knabbe Cornelius, Dreier Jens
机构信息
Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
出版信息
Transfus Med Hemother. 2016 Nov;43(6):425-427. doi: 10.1159/000450794. Epub 2016 Nov 2.
Abstract
摘要
相似文献
1
Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening.知识即安全：戊型肝炎病毒献血者筛查时机已成熟。
Transfus Med Hemother. 2016 Nov;43(6):425-427. doi: 10.1159/000450794. Epub 2016 Nov 2.
2
The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.荷兰是乙肝病毒低流行国家，其乙肝核心抗原供体筛查通用抗体的检出率
Transfusion. 2015 Jun;55(6):1206-13. doi: 10.1111/trf.12962. Epub 2014 Dec 15.
3
New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.一名献血者体内新的乙型肝炎病毒突变形式，在几种乙型肝炎表面抗原筛查检测中均无法检测到。
Transfusion. 1998 Jan;38(1):56-9. doi: 10.1046/j.1537-2995.1998.38198141499.x.
4
Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety.人类免疫缺陷病毒1型、丙型肝炎病毒和乙型肝炎病毒的个体供者核酸检测及其在血液安全中的作用
Asian J Transfus Sci. 2015 Jul-Dec;9(2):199-202. doi: 10.4103/0973-6247.154250.
5
[The screening of donor blood on antibodies to nuclear antigen of hepatitis B virus as a tool of increasing of safety of transfusion for patients with diseases of blood system.].[对献血者血液进行乙肝病毒核抗原抗体筛查作为提高血液系统疾病患者输血安全性的一种手段。]
Klin Lab Diagn. 2016;61(5):311-316. doi: 10.18821/0869-2084-2016-61-5-311-316.
6
The History and Challenges of Blood Donor Screening in China.中国献血者筛查的历史与挑战
Transfus Med Rev. 2017 Apr;31(2):89-93. doi: 10.1016/j.tmrv.2016.11.001. Epub 2016 Nov 12.
7
Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.输血传播的戊型肝炎：献血的核酸检测筛查与感染剂量
Front Med (Lausanne). 2018 Feb 1;5:5. doi: 10.3389/fmed.2018.00005. eCollection 2018.
8
Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.在血库环境中对献血者进行丙型肝炎病毒、乙型肝炎病毒和HIV-1常规PCR筛查的可行性和有效性。
Lancet. 1999 Jan 30;353(9150):359-63. doi: 10.1016/S0140-6736(98)06318-1.
9
Detection of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in postmortem blood specimens using infectious disease assays licensed for cadaveric donor screening.使用经许可用于尸体供体筛查的传染病检测方法，对死后血液标本中的人类免疫缺陷病毒、丙型肝炎病毒和乙型肝炎病毒进行检测。
Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12825. Epub 2018 Jan 19.
10
Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results.
Transfusion. 1998 Oct;38(10):905-7. doi: 10.1046/j.1537-2995.1998.381098440853.x.
引用本文的文献
1
Blood Donor Screening for Hepatitis E Virus in the European Union.欧盟戊型肝炎病毒献血者筛查
Transfus Med Hemother. 2019 Apr;46(2):95-103. doi: 10.1159/000499121. Epub 2019 Mar 14.
2
Transmission and Epidemiology of Hepatitis E Virus Genotype 3 and 4 Infections.戊型肝炎病毒基因型 3 和 4 感染的传播和流行病学。
Cold Spring Harb Perspect Med. 2018 Nov 1;8(11):a032144. doi: 10.1101/cshperspect.a032144.
3
Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.输血传播的戊型肝炎：献血的核酸检测筛查与感染剂量
Front Med (Lausanne). 2018 Feb 1;5:5. doi: 10.3389/fmed.2018.00005. eCollection 2018.
本文引用的文献
1
Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.2011年德国献血者中的戊型肝炎：无症状感染自然病程调查
Euro Surveill. 2016 Sep 1;21(35). doi: 10.2807/1560-7917.ES.2016.21.35.30332.
2
Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.血液制品中的戊型肝炎病毒：英格兰东南部的流行率和传播研究。
Lancet. 2014 Nov 15;384(9956):1766-73. doi: 10.1016/S0140-6736(14)61034-5. Epub 2014 Jul 28.
3
Hepatitis E screening for blood donations: an urgent need?献血中的戊型肝炎筛查：迫切需要吗？
Lancet. 2014 Nov 15;384(9956):1729-30. doi: 10.1016/S0140-6736(14)61187-9. Epub 2014 Jul 28.
4
Past and present of hepatitis E in the Netherlands.荷兰戊型肝炎的过去与现在。
Transfusion. 2014 Dec;54(12):3092-6. doi: 10.1111/trf.12733. Epub 2014 May 29.
5
Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma.血清学和分子证据表明，混合血浆可能传播戊型肝炎病毒。
Vox Sang. 2014 Oct;107(3):213-9. doi: 10.1111/vox.12156. Epub 2014 May 15.
6
Comparison of real-time PCR and antigen assays for detection of hepatitis E virus in blood donors.用于检测献血者中戊型肝炎病毒的实时聚合酶链反应与抗原检测法的比较
J Clin Microbiol. 2014 Jun;52(6):2150-6. doi: 10.1128/JCM.03578-13. Epub 2014 Apr 16.
7
Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.德国血液筛查 HIV-1 核酸扩增技术检测的风险最小化措施。
Transfus Med Hemother. 2014 Feb;41(1):45-51. doi: 10.1159/000357103. Epub 2013 Dec 19.
8
Hepatitis E transmission by transfusion of Intercept blood system-treated plasma.通过输注经Intercept血液系统处理的血浆传播戊型肝炎。
Blood. 2014 Jan 30;123(5):796-7. doi: 10.1182/blood-2013-09-524348.
9
Should we screen blood products for hepatitis E virus RNA ?我们应该对血液制品进行戊型肝炎病毒RNA筛查吗？
Lancet. 2014 Jan 18;383(9913):218. doi: 10.1016/S0140-6736(14)60072-6.
10
Hepatitis E virus infection.戊型肝炎病毒感染。
Clin Microbiol Rev. 2014 Jan;27(1):116-38. doi: 10.1128/CMR.00057-13.
Zotero 插件